Effects of stopping bisphosphonate treatment on height, weight, BMD and bone turnover in children with Osteogenesis Imperfecta (OI)

被引：0
|
作者：
DiMeglio, L. A. [1 ]
Ford, L. [1 ]
Peacock, M. [1 ]
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
来源：
BONE | 2007年 / 40卷 / 06期
关键词：
D O I：
10.1016/j.bone.2007.04.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [31] RESOLUTION OF EFFECTS ON BONE TURNOVER MARKERS AND BMD AFTER DISCONTINUATION OF LONG-TERM BISPHOSPHONATE USE
    De Villiers, Tobias
    Benhamou, Claude
    Johnston, C. Conrad
    Langdahl, Bente
    Saag, Kenneth
    Denker, Andrew
    Pong, Annpey
    Mcginnis, John, II
    Rosenberg, Elizabeth
    Santora, Arthur
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S138 - S138
  • [32] Effects of pamidronate on bone modeling, bone remodeling and degree of mineralization of bone from children with osteogenesis imperfecta
    Boivin, G
    Chavassieux, P
    Forin, V
    Pinto, G
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S24 - S24
  • [33] Gain in BMD and grip strength after one year of pamidronate treatment in 132 children with osteogenesis imperfecta.
    Plotkin, H
    Montpetit, K
    Cloutier, S
    Bilodeau, N
    Gervais, N
    Rabzel, M
    Travers, R
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S484 - S484
  • [34] Effects of different bisphosphonates on bone metabolism in children with osteogenesis imperfecta. pre study
    Papassotiriou, I.
    Matsinos, G.
    Douskas, G.
    Prountzou-Kassiou, K.
    BONE, 2007, 40 (06) : S308 - S309
  • [35] The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta
    Biggin, Andrew
    Zheng, Linda
    Briody, Julie N.
    Coorey, Craig P.
    Munns, Craig F.
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 83 (03): : 183 - 189
  • [36] COMPUTED-TOMOGRAPHY (CT) BONE-DENSITY IN CHILDREN WITH OSTEOGENESIS IMPERFECTA (OI), INFANTS WITH MULTIPLE UNEXPLAINED FRACTURES (MUF), AND CONTROLS
    MILLER, ME
    HANGARTNER, TN
    PEDIATRIC RESEARCH, 1995, 37 (04) : A150 - A150
  • [37] Early treatment with intravenous bisphosphonates prevents severe postnatal bone loss in children with Osteogenesis imperfecta
    Rehberg, Mirko
    Heistermann, Johanna
    Schoenau, Eckhard
    Semler, Joerg
    Hoyer-Kuhn, Heike
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 125 - 126
  • [38] Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
    Horwitz, EM
    Prockop, DJ
    Fitzpatrick, LA
    Koo, WWK
    Gordon, PL
    Neel, M
    Sussman, M
    Orchard, P
    Marx, JC
    Pyeritz, RE
    Brenner, MK
    NATURE MEDICINE, 1999, 5 (03) : 309 - 313
  • [39] A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta
    Bains, Jaskaran S.
    Carter, Erin M.
    Citron, Kate P.
    Boskey, Adele L.
    Shapiro, Jay R.
    Steiner, Robert D.
    Smith, Peter A.
    Bober, Michael B.
    Hart, Tracy
    Cuthbertson, David
    Krischer, Jeff
    Byers, Peter H.
    Pepin, Melanie
    Durigova, Michaela
    Glorieux, Francis H.
    Rauch, Frank
    Sliepka, Joseph M.
    Sutton, V. Reid
    Lee, Brendan
    Nagamani, Sandesh C. S.
    Raggio, Cathleen L.
    JBMR PLUS, 2019, 3 (05)
  • [40] Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
    Edwin M. Horwitz
    Darwin J. Prockop
    Lorraine A. Fitzpatrick
    Winston W. K. Koo
    Patricia L. Gordon
    Michael Neel
    Michael Sussman
    Paul Orchard
    Jeffrey C. Marx
    Reed E. Pyeritz
    Malcolm K. Brenner
    Nature Medicine, 1999, 5 : 309 - 313
12345